The Answer AI Platform partners with RAIQC

13th February 2025

We are excited to announce our partnership with RAIQC, a leader in medical image interpretation and AI innovation. This collaboration brings together cutting-edge technology and healthcare expertise to drive meaningful advancements in NHS diagnostics, efficiency, and patient care.


Our partnership with RAIQC is built on a shared mission: to help the NHS deliver faster, more effective, and cost-efficient care for every patient. By accelerating AI deployment, we are enabling healthcare providers to improve diagnostic accuracy, enhance operational efficiency, and prevent diseases through early detection, ultimately transforming patient outcomes.


To achieve this, our services align closely with the NHS’s existing missions for health and social care delivery, providing an end-to-end solution for AI adoption. From model development and evaluation to clinical implementation and post-market surveillance, we are ensuring AI solutions are not only cutting-edge but also fully integrated, safe, and impactful. Together, we are paving the way for a smarter, data-driven healthcare system that puts patients first.

Our AI offering

RAIQC offering.png

The Answer AI Platform empowers organisations to seamlessly integrate AI at scale. Built for flexibility, it enables standardisation across networks while allowing choice in AI models and systems.

Originally deployed across seven NHS Trusts with national funding, earning AI Project of the Year at the UKIT Industry Awards 2024. Our platform simplifies AI adoption, from selection and clinical integration to ongoing monitoring through intelligent post-market surveillance.


We’ve collaborated with leading AI vendors across imaging specialities, ensuring rapid deployment and building clinical confidence in AI’s value. Designed for networks seeking a unified AI strategy, our platform supports structured education, intelligent cross-site reporting, and smart backlog management, maximising efficiency and reducing waiting lists.

Beyond clinical adoption, our platform fuels innovation. It serves as an education hub for training future clinicians and an incubator for academic and start-up AI models, embedding interoperability and governance from the outset.

Now, we’re expanding this proven approach to more organisations, accelerating AI adoption and transforming patient care.

RAIQC: driving trust in AI and healthcare

RAIQC is an Oxford University Hospitals spin-out revolutionising AI adoption in healthcare. With a focus on trust, transparency, and real-world impact, RAIQC provides an end-to-end solution that ensures AI tools are rigorously tested, clinicians are fully trained, and performance is continuously monitored.

Its three-pronged approach gives healthcare providers the confidence to integrate AI effectively:

Pre-Market Evaluation (PME): Compare AI tools side-by-side using local data to determine which delivers the best results for your patient population.

End-User Education (EDU): A clinical simulation platform using real-world anonymised cases to train healthcare professionals in AI’s strengths and limitations, fully integrated with hospital training logs.

Post-Market Surveillance (PMS): A powerful monitoring tool using natural language processing to track AI performance over time, detect degradation, and assess downstream impacts like length of stay, clinic attendance, and follow-up imaging.

With RAIQC, AI adoption isn’t a leap of faith, it’s a data-driven, clinically assured process that ensures technology works for both patients and practitioners.

About Dr. Sarim Ather

Dr Ather is a Consultant Radiologist and Radiology AI Lead at Oxford University Hospitals NHS Foundation Trust. He has completed a PhD in neuroimaging and has a keen interest in the application of digital technologies in health care. At Oxford, Dr Ather works with a multidisciplinary group including data scientists and computer vision experts to develop and validate radiology artificial intelligence algorithms in a range of disease areas from arthritis to lung cancer.

If you would like to know more about how this partnership can benefit your Trust, get in touch.







Let’s create something remarkable together

Get In Touch